Pooled safety analysis of lebrikizumab in patients with uncontrolled asthma from three randomized clinical trials

被引：0

作者：

Corren, Jonathan ^{[1
,2
]}

Szefler, Stanley J. ^{[3
]}

Armstrong, April W. ^{[4
,5
]}

Natalie, Chitra R. ^{[6
]}

Zitnik, Ralph ^{[7
]}

Zhao, Fangyi ^{[6
]}

Siu, Kimberly ^{[6
]}

Lio, Peter A. ^{[8
]}

Mourey, Robert J. ^{[6
]}

机构：

[1] UCLA, Dept Med, David Geffen Sch Med, Los Angeles, CA USA

[2] UCLA, Dept Pediat, Div Allergy & Clin Immunol, David Geffen Sch Med, Los Angeles, CA USA

[3] Univ Colorado, Childrens Hosp Colorado, Sch Med, Aurora, CO USA

[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA

[5] Clin Res Southern Calif Clin & Translat Res Inst, Los Angeles, CA USA

[6] Eli Lilly & Co, Indianapolis, IN USA

[7] Valerio Consulting LLC, Santa Barbara, CA USA

[8] Northwestern Univ, Med Dermatol Associates Chicago, Feinberg Sch Med, Chicago, IL USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

lebrikizumab; asthma; interleukin-13;

D O I：

10.1093/bjd/ljad162.022

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

399

引用

页数：2

共 50 条

[1] POOLED SAFETY ANALYSIS OF LEBRIKIZUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA FROM THREE RANDOMIZED CLINICAL TRIALS
Corren, J.
Szefler, S.
Armstrong, A.
Natalie, C.
Zitnik, R.
Zhao, F.
Siu, K.
Lio, P.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S34 - S35
[2] Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials
Virchow, J. Christian
Katial, Rohit
Brusselle, Guy G.
Shalit, Yael
Garin, Margaret
McDonald, Mirna
Castro, Mario
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 540 - +
[3] Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma
Liu, Ying
Zhang, SuZhong
Chen, Ruie
Wei, Jieshu
Guan, Guanheng
Zhou, Manru
Dong, Nan
Cao, Yingnan
ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (05) : 332 - 337
[4] Safety of Foradil® in the treatment of asthma:: A pooled analysis of randomized, controlled clinical trials
Geba, GP
Ziehmer, B
Staudinger, H
Till, D
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S196 - S196
[5] The Effect Of Lebrikizumab Therapy On Key Type 2 Biomarkers In Moderate-To-Severe, Uncontrolled Asthma Patients: A Pooled Analysis From Phase 2 Trials
Hanania, N. A.
Korenblat, P.
Corren, J.
Olsson, J.
Kamath, N.
Gray, S.
Martin, N.
Holweg, C. T. J.
Matthews, J. G.
Scheerens, H.
Limb, S. L.
Korom, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[6] Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
Szefler, Stanley J.
Roberts, Graham
Rubin, Adalberto S.
Zielen, Stefan
Kuna, Piotr
Alpan, Oral
Anzures-Cabrera, Judith
Chen, Qiang
Holweg, Cecile T. J.
Kaminski, Janusz
Putnam, Wendy S.
Matthews, John G.
Kamath, Nikhil
CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (07)
[7] Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials
Xiong, Xiao-feng
Zhu, Min
Wu, Hong-xia
Fan, Li-li
Cheng, De-yun
RESPIRATORY RESEARCH, 2019, 20 (1)
[8] Efficacy and Safety of Dupilumab for the Treatment of Uncontrolled Asthma: A Meta-Analysis of Randomized Clinical Trials
Xiong, X.
Cheng, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[9] Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials
Xiao-feng Xiong
Min Zhu
Hong-xia Wu
Li-li Fan
De-yun Cheng
Respiratory Research, 20
[10] Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials
Mease, Philip
Roussou, Euthalia
Burmester, Gerd-Ruediger
Goupille, Philippe
Gottlieb, Alice
Moriarty, Susan R.
Benichou, Olivier
Adams, David H.
Xu, Wen
Nash, Peter
ARTHRITIS CARE & RESEARCH, 2019, 71 (03) : 367 - 378

← 1 2 3 4 5 →